The relationships of these indicators of oxidant exposure, in particular the Ox-E/ER gene signature, to breast cancer biology and clinical outcome are further explored using microarray data from 394 ER-positive primary human breast cancers pooled from three independently published studies. Here, ESR1 is linked to breast carcinoma.